June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Ocular Effects of Blood Collection Techniques in Rabbits
Author Affiliations & Notes
  • Shwu-Fei Lee
    Nonclinical Safety Assessment, Covance Laboratories Inc., Madison, WI
  • Steven Sorden
    Nonclinical Safety Assessment, Covance Laboratories Inc., Madison, WI
  • Dale Dunn
    Nonclinical Safety Assessment, Covance Laboratories Inc., Madison, WI
  • Peter Sonnentag
    Nonclinical Safety Assessment, Covance Laboratories Inc., Madison, WI
  • Alexander Dwyer
    College of Veterinary Medicine, Iowa State University, Ames, IA
  • Footnotes
    Commercial Relationships Shwu-Fei Lee, Covance Laboratories Inc. (E); Steven Sorden, Covance Laboratories, Inc. (E); Dale Dunn, Covance Laboratories Inc. (E); Peter Sonnentag, Covance Laboratories Inc. (E); Alexander Dwyer, Covance Inc (E), Covance Inc (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3039. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shwu-Fei Lee, Steven Sorden, Dale Dunn, Peter Sonnentag, Alexander Dwyer; Ocular Effects of Blood Collection Techniques in Rabbits. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3039.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Rabbits are commonly used in nonclinical safety evaluation of ophthalmic drugs. To reduce the number of animals, blood samples for toxicokinetic (TK) and toxicity tests are often taken from the same animals. Medial auricular artery catheterization is common when >4 TK timepoints are needed in one day. Potential catheterization-related ocular lesions occurred in previous rabbit studies. This study evaluated ocular effects of various blood collection techniques in rabbits.

Methods: 50 female Hra:(NZW)SPF rabbits were assigned to 5 groups (10 animals/group). On Days 1 and 7, blood was collected at 7 timepoints in an 8-hour interval via repeated hypodermic needle puncture of a medial auricular artery (Group 1), a jugular vein (Group 2), or a combination of medial auricular artery and a jugular vein (Group 3); or via a medial auricular artery catheter (Group 4). Group 5 had a catheter without a needle taped to the surface of one pinna (control for Group 4, no blood collected). Clinical signs, dermal irritation at collection sites, body weight, and anatomic pathology were assessed.

Results: Skin lesions or irritation at the collection/sham sites occurred in all groups. Jugular venipuncture sites had the most severe skin irritation and resulted in the fewest useable samples. Ear artery catheterization yielded the most useable samples and caused only minor skin lesions but was associated with multiple foci of necrosis/acute inflammation or subacute inflammation in Harderian and lacrimal glands. Findings correlated with catheter site, i.e., only animals with a catheter in the right ear had findings in right Harderian and/or lacrimal gland. Unilateral multifocal necrosis/acute inflammation in the mandibular salivary gland and focal degeneration/necrosis in the brain were also restricted to catheterized animals. Groups 1 and 3 only had microscopic lesions at intraartery sites. Group 2 had no technique-related microscopic lesions.

Conclusions: Repeated blood collection via ear artery catheter can result in foci of necrosis and inflammation in paraocular and mandibular salivary glands. Paraocular gland lesions could confound microscopic assessment of ophthalmic drugs. A combination of jugular vein and ear artery collections is a reasonable alternative with minimal samples missed. However, a satellite group for TK sample collections is recommended for ocular toxicity studies in rabbits.

Keywords: 637 pathology: experimental • 620 ocular irritancy/toxicity testing • 576 lacrimal gland  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.